Six notes:
1. Researchers monitored saliva and blood samples from more than 400 patients for up to a year and a half for the study.
2. The saliva samples were tested for 10 inflammation-related proteins, while the blood samples were tested for five.
3. The study showed that on average, patients with a moderate to severe progression of gum disease had substantial increases in nine inflammation-related signaling proteins in their saliva.
4. The protein levels were shown to subside after treatment, according to a Jan. 7 news release.
5. The levels of certain proteins in the blood samples did not differ significantly by degree of disease progression, although other proteins did decrease significantly after treatment.
6. The study’s lead author, Flavia Teles, DDS, said in the news release that saliva test kits could be a more personalized tool that patients can use at home.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
